Chun-Su Yuan to Gastrointestinal Transit
This is a "connection" page, showing publications Chun-Su Yuan has written about Gastrointestinal Transit.
Connection Strength
1.031
-
Tolerability, gut effects, and pharmacokinetics of methylnaltrexone following repeated intravenous administration in humans. J Clin Pharmacol. 2005 May; 45(5):538-46.
Score: 0.254
-
Effects of enteric-coated methylnaltrexone in preventing opioid-induced delay in oral-cecal transit time. Clin Pharmacol Ther. 2000 Apr; 67(4):398-404.
Score: 0.178
-
Effects of intravenous methylnaltrexone on opioid-induced gut motility and transit time changes in subjects receiving chronic methadone therapy: a pilot study. Pain. 1999 Dec; 83(3):631-635.
Score: 0.174
-
The safety and efficacy of oral methylnaltrexone in preventing morphine-induced delay in oral-cecal transit time. Clin Pharmacol Ther. 1997 Apr; 61(4):467-75.
Score: 0.145
-
Methylnaltrexone prevents morphine-induced delay in oral-cecal transit time without affecting analgesia: a double-blind randomized placebo-controlled trial. Clin Pharmacol Ther. 1996 Apr; 59(4):469-75.
Score: 0.135
-
Effects of subcutaneous methylnaltrexone on morphine-induced peripherally mediated side effects: a double-blind randomized placebo-controlled trial. J Pharmacol Exp Ther. 2002 Jan; 300(1):118-23.
Score: 0.050
-
Methylnaltrexone for reversal of constipation due to chronic methadone use: a randomized controlled trial. JAMA. 2000 Jan 19; 283(3):367-72.
Score: 0.044
-
Gut motility and transit changes in patients receiving long-term methadone maintenance. J Clin Pharmacol. 1998 Oct; 38(10):931-5.
Score: 0.040
-
Familial megacecum and colon in the rat: a new model of gastrointestinal neuromuscular dysfunction. Lab Anim Sci. 1998 Jun; 48(3):243-52.
Score: 0.010